{"organizations": [], "uuid": "cbbd237b1266b4a38b7b5e33e4b374b37d40700b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-veloxis-pharmaceuticals-says-cos-c/brief-veloxis-pharmaceuticals-says-cos-capital-has-increased-by-200000-new-shares-after-exercise-of-warrants-by-former-employees-idUSFWN1QX17N", "country": "US", "domain_rank": 408, "title": "BRIEF-Veloxis Pharmaceuticals says Co's capital has increased by 200,000 new shares after exercise of warrants by former employees", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-16T10:17:00.000+02:00", "replies_count": 0, "uuid": "cbbd237b1266b4a38b7b5e33e4b374b37d40700b"}, "author": "", "url": "https://www.reuters.com/article/brief-veloxis-pharmaceuticals-says-cos-c/brief-veloxis-pharmaceuticals-says-cos-capital-has-increased-by-200000-new-shares-after-exercise-of-warrants-by-former-employees-idUSFWN1QX17N", "ord_in_thread": 0, "title": "BRIEF-Veloxis Pharmaceuticals says Co's capital has increased by 200,000 new shares after exercise of warrants by former employees", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-veloxis pharmaceuticals", "sentiment": "negative"}, {"name": "co", "sentiment": "negative"}, {"name": "market news march 16", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News March 16, 2018 / 8:18 AM / Updated an hour ago BRIEF-Veloxis Pharmaceuticals says Co's capital has increased by 200,000 new shares after exercise of warrants by former employees Reuters Staff 1 Min Read March 16 (Reuters) - Veloxis Pharmaceuticals A/S: * VELOXIS PHARMACEUTICALS- CO CAPITAL HAS INCREASED BY 200,000 NEW SHARES WITH A NOMINAL VALUE OF DKK 0.10 EACH CORRESPONDING TO NOMINALLY DKK 20,000​ * VELOXIS PHARMACEUTICALS - ‍AS RESULT OF EMPLOYEE’S INVESTMENT IN CO’S PROCEEDS TO VELOXIS PHARMACEUTICALS FROM CAPITAL INCREASE AMOUNTS TO DKK 70,000​ * VELOXIS PHARMACEUTICALS A/S SAYS ‍SUBSCRIPTION PRICE FOR NEW SHARES IS DKK 0.35 PER SHARE OF NOMINAL DKK 0.10​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-16T10:17:00.000+02:00", "crawled": "2018-03-16T10:40:43.026+02:00", "highlightTitle": ""}